What is Samseng Tissue?
Based in Burlington, New Jersey, Samseng Tissue operates as a family-owned enterprise specializing in the production of away-from-home tissue products. Since its inception in 2014, the company has carved out a distinct market position by offering private label solutions and contract converting services. By prioritizing supply chain efficiency and high-quality output, the firm serves as a critical partner for vendors requiring reliable, cost-effective paper manufacturing. Their business model emphasizes exceptional service and timely delivery, which has allowed them to maintain a steady growth trajectory in a sector often dominated by larger, less agile competitors.
How much funding has Samseng Tissue raised?
Samseng Tissue has raised a total of $102K across 1 funding round:
Debt
$102K
Debt (2021): $102K with participation from PPP
Key Investors in Samseng Tissue
PPP
Public-Private Partnership
What's next for Samseng Tissue?
The recent infusion of capital is expected to catalyze the next phase of the company's expansion, likely focusing on scaling production capacity and enhancing technological integration within their manufacturing facilities. As the firm transitions through this late-stage funding cycle, management will likely prioritize operational optimization to meet the increasing demand for private label tissue products. By leveraging this financial backing, Samseng Tissue is poised to strengthen its market share and potentially explore new distribution channels, ensuring sustained relevance in the evolving industrial paper market.
See full Samseng Tissue company page
